UB Paderborn / Katalog / Suche / in CDI

Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-07, Vol.14 (4), p.729-735

2008

Volltextzugriff (PDF)

An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-05, Vol.17 (3), p.439-445

2011

Volltextzugriff (PDF)

Reliability of five rapid D-dimer assays compared to ELISA in the exclusion of deep venous thrombosis

Thrombosis and haemostasis, 1997-02, Vol.77 (2), p.262

1997

Volltextzugriff (PDF)

Misleading one-stage coagulation factor assay during rFVIIa treatment in lupus patient

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-09, Vol.15 (5), p.1164-1166

2009

Volltextzugriff (PDF)

Pseudotumor occurring in hemophilia

Archives of orthopaedic and trauma surgery, 2000, Vol.120 (7-8), p.476-478

2000

Volltextzugriff (PDF)

A clinical and cardiovascular survey of Ehlers-Danlos syndrome patients with complete deficiency of tenascin-X

Netherlands journal of medicine, 2004-05, Vol.62 (5), p.160-162

2004

Volltextzugriff (PDF)

Prevention of symptomatic thrombosis with short term (low molecular weight) heparin in patients with rheumatoid arthritis after hip or knee replacement

Annals of the rheumatic diseases, 2001-10, Vol.60 (10), p.974-976

2001

Volltextzugriff (PDF)

D-dimer determination to assess regression of deep venous thrombosis

Thrombosis and haemostasis, 1997-08, Vol.78 (2), p.799

1997

Volltextzugriff (PDF)

In vivo recovery and safety of human factor VIII product AAFACT® in patients with haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2003-03, Vol.9 (2), p.157-163

2003

Volltextzugriff (PDF)

Homozygous cystathionine β-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis

Blood, 1998-03, Vol.91 (6), p.2015-2018

1998

Volltextzugriff (PDF)

An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies: PHASE III/IV STUDIES WITH PLASMA FIX (NONAFACT®)

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-05, Vol.17 (3), p.439-445

2011

Volltextzugriff (PDF)

Ceftazidime with or without amikacin for the empiric treatment of localized infections in febrile, granulocytopenic patients

Annals of hematology, 1991-10, Vol.63 (4), p.195-200

1991

Volltextzugriff (PDF)

Evaluation of the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic approach to determine Glanzmann Thrombasthenia in blood platelet lysates

Journal of thrombosis and haemostasis, 2003-07, Vol.1, p.OC175-OC175

2003

Volltextzugriff (PDF)

Homocysteine concentrations are associated with increased t-PA and PAI concentrations in smokers

Journal of thrombosis and haemostasis, 2003-07, Vol.1, p.P0418-P0418

2003

Volltextzugriff (PDF)

Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis

Thrombosis and haemostasis, 1995, Vol.74 (5), p.1276

1995

Volltextzugriff (PDF)

FACTOR VIIA DETERMINATION COMPARED TO D-DIMER IN DIAGNOSIS OF DEEP VENOUS THROMBOSIS

Thrombosis research, 1997-06, Vol.86 (5), p.423-426

1997

Volltextzugriff (PDF)

Virus Transmission by Subcutaneous Jet Injection

Journal of medical microbiology, 1985-12, Vol.20 (3), p.393-397

1985

Volltextzugriff (PDF)

Long term follow up of radiosynovectomy with yttrium-90 silicate in haemophilic haemarthrosis

Annals of the rheumatic diseases, 1993-07, Vol.52 (7), p.548-550

1993

Volltextzugriff (PDF)

Prevention of symptomatic thrombosis with short term heparin in patients with rheumatoid arthritis after hip or knee replacement

Annals of the rheumatic diseases, 2001-10, Vol.60 (6), p.974

2001

Volltextzugriff (PDF)

New developments in the treatment of deep venous thrombosis

Netherlands journal of medicine, 1997-01, Vol.50 (1), p.36

1997

Volltextzugriff (PDF)

Teicoplanin as modification of initial empirical therapy in febrile granulocytopenic patients

Journal of antimicrobial chemotherapy, 1990-06, Vol.25 (6), p.985-993

1990

Volltextzugriff (PDF)

Familial cerebrovascular accidents due to concomitant hyperhomocysteinemia and protein C deficiency type 1

Stroke (1970), 1993-10, Vol.24 (10), p.1599-1600

1993

Volltextzugriff (PDF)

Diagnosis of deep vein thrombosis, an overview

Netherlands journal of medicine, 1996-03, Vol.48 (3), p.109

1996

Volltextzugriff (PDF)

Rapid D-Dimer assays to exclude deep venous thrombosis and pulmonary embolism : Current status and new developments: New developments in diagnosis and management of venous thromboembolism

Seminars in thrombosis and hemostasis, 1998, Vol.24 (4), p.393-400

1998

Volltextzugriff (PDF)

Options and limitations of teicoplanin in febrile granulocytopenic patients

British journal of haematology, 1990-12, Vol.76 (s2), p.1-5

1990

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations

An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies

Reliability of five rapid D-dimer assays compared to ELISA in the exclusion of deep venous thrombosis

Misleading one-stage coagulation factor assay during rFVIIa treatment in lupus patient

Pseudotumor occurring in hemophilia

A clinical and cardiovascular survey of Ehlers-Danlos syndrome patients with complete deficiency of tenascin-X

Prevention of symptomatic thrombosis with short term (low molecular weight) heparin in patients with rheumatoid arthritis after hip or knee replacement

D-dimer determination to assess regression of deep venous thrombosis

In vivo recovery and safety of human factor VIII product AAFACT® in patients with haemophilia A

Homozygous cystathionine β-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis

An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies: PHASE III/IV STUDIES WITH PLASMA FIX (NONAFACT®)

Ceftazidime with or without amikacin for the empiric treatment of localized infections in febrile, granulocytopenic patients

Evaluation of the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic approach to determine Glanzmann Thrombasthenia in blood platelet lysates

Homocysteine concentrations are associated with increased t-PA and PAI concentrations in smokers

Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis

FACTOR VIIA DETERMINATION COMPARED TO D-DIMER IN DIAGNOSIS OF DEEP VENOUS THROMBOSIS

Virus Transmission by Subcutaneous Jet Injection

Long term follow up of radiosynovectomy with yttrium-90 silicate in haemophilic haemarthrosis

Prevention of symptomatic thrombosis with short term heparin in patients with rheumatoid arthritis after hip or knee replacement

New developments in the treatment of deep venous thrombosis

Teicoplanin as modification of initial empirical therapy in febrile granulocytopenic patients

Familial cerebrovascular accidents due to concomitant hyperhomocysteinemia and protein C deficiency type 1

Diagnosis of deep vein thrombosis, an overview

Rapid D-Dimer assays to exclude deep venous thrombosis and pulmonary embolism : Current status and new developments: New developments in diagnosis and management of venous thromboembolism

Options and limitations of teicoplanin in febrile granulocytopenic patients

Suchergebnisse filtern